Cases – Page 66 – ClaimsFiler

Recent Security Class Actions

Tiffany & Co. (NYSE: TIF)

According to the Complaint, Tiffany & Co. operates more than 300 retail stores worldwide.

According to the Complaint, Synthorx is a clinical-stage biotechnology company focused on prolonging and improving the lives of people with cancer and autoimmune disorders.

According to the Complaint, Forescout Technologies, Inc. provides network security products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and Japan, selling its products and services through distributors and resellers.

Sign up today for FREE to gain access to full case information AND get real time case monitoring for your investment accounts.

ArQule, Inc. (NASDAQ: ARQL)

According to the Complaint, ArQule, Inc. is a biopharmaceutical company engaged in the research and development of targeted therapeutics to treat cancers and rare diseases.

According to the Complaint, Trulieve, together with its subsidiaries, purports to operate as a medical marijuana company. The Company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as directly to patients through home delivery.

According to the Complaint, Mattel designs, manufactures, and markets a range of toy products worldwide. Its portfolio of brands and products include such household names as FisherPrice, Barbie, Hot Wheels, Matchbox, Masters of the Universe, American Girl and Thomas & Friends. The Company purports to be the owner of one of the strongest portfolios of toy brands in the world with vast intellectual property potential.

Sign up today for FREE to gain access to full case information AND get real time case monitoring for your investment accounts.

According to the Complaint, Tech Data Corporation is one of the world’s largest IT distribution and solutions companies and is ranked No. 88 on the Fortune 500®.

According to the Complaint, Correvio Pharma Corp. is a specialty pharmaceutical company that engages in developing therapeutics worldwide. The Company's portfolio of marketed brands comprise, among others,
vernakalant IV, or Brinavess, for the rapid conversion of recent onset AF to sinus rhythm.

Sign up today for FREE to gain access to full case information AND get real time case monitoring for your investment accounts.

According to the Complaint, Baxter International Inc. provides a broad portfolio of essential healthcare products, including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, and surgical hemostat and sealant products.